A trial evaluated the short-term oncologic efficacy of cooled focal therapy ablation using the ProFocal device in men with localized, intermediate-risk prostate cancer.
A Loughborough University student has developed a new medical device that could transform how prostate health is assessed and monitored. Devon Tyso, a Product Design and Technology student, has ...
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Now, I know what you’re thinking. “Prostate health ...
Less than a week after making a regulatory submission for a $1 million capital raise, prostate health company ProUroCare Medical, based in Eden Prairie, Minnesota, announced that it has secured market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results